Advances in the management of peritoneal malignancies
Peritoneal surface malignancies (PSMs) are usually associated with a poor prognosis.
Nonetheless, in line with advances in the management of most abdominopelvic metastatic …
Nonetheless, in line with advances in the management of most abdominopelvic metastatic …
Malignant peritoneal mesothelioma: an in-depth and up-to-date review of pathogenesis, diagnosis, management and future directions
JB Karpes, R Shamavonian, S Dewhurst, E Cheng… - Cancers, 2023 - mdpi.com
Simple Summary Mesothelioma is a malignancy of mesothelial tissues. The majority arise
from the pleura, but approximately thirty percent of cases arise from the peritoneum …
from the pleura, but approximately thirty percent of cases arise from the peritoneum …
Organoids derived from patients provide a new opportunity for research and individualized treatment of malignant peritoneal mesothelioma
XC Fang, L Shu, TL Chen, XL Zhao, LC Yang, T Dou… - Molecular Cancer, 2024 - Springer
Background Malignant peritoneal mesothelioma (MPM) is an extremely rare and highly
invasive tumor. Due to the lack of accurate models that reflect the biological characteristics …
invasive tumor. Due to the lack of accurate models that reflect the biological characteristics …
Guidelines for pathologic diagnosis of mesothelioma: 2023 update of the consensus statement from the international mesothelioma interest group
AN Husain, DB Chapel, R Attanoos… - … of Pathology & …, 2024 - meridian.allenpress.com
Context.—Mesothelioma is an uncommon tumor that can be difficult to diagnose. Objective.—
To provide updated, practical guidelines for the pathologic diagnosis of mesothelioma. Data …
To provide updated, practical guidelines for the pathologic diagnosis of mesothelioma. Data …
Diagnostic and therapeutic pathway in diffuse malignant peritoneal mesothelioma
S Kusamura, D Baratti, M De Simone, EM Pasqual… - Cancers, 2023 - mdpi.com
Simple Summary Mesothelioma is a rare cancer that originates in mesothelial surfaces of
the peritoneum, pleura, and other sites. Diffuse malignant peritoneal mesothelioma (DMPM) …
the peritoneum, pleura, and other sites. Diffuse malignant peritoneal mesothelioma (DMPM) …
EWSR1::YY1 fusion positive peritoneal epithelioid mesothelioma harbors mesothelioma epigenetic signature: Report of 3 cases in support of an emerging entity
JK Dermawan, D Torrence, CH Lee… - Genes …, 2022 - Wiley Online Library
Mesothelioma is a rare, aggressive malignant neoplasm of mesothelial origin. A small
subset of peritoneal mesothelioma is driven by recurrent gene fusions, mostly EWSR1/FUS …
subset of peritoneal mesothelioma is driven by recurrent gene fusions, mostly EWSR1/FUS …
Peritoneal mesothelioma—an update
A Malpica - Advances in anatomic pathology, 2023 - journals.lww.com
A remarkable amount of new information has been generated on peritoneal mesothelioma
(PeM), ranging from nomenclature changes, including the removal of “malignant” when …
(PeM), ranging from nomenclature changes, including the removal of “malignant” when …
Characterizing the distribution of alterations in mesothelioma and their correlation to morphology
HIH Chen-Yost, MY Tjota, G Gao… - American Journal of …, 2023 - academic.oup.com
Objectives Mesothelioma is a lethal disease that arises from the serosal lining of organ
cavities. Several recurrent alterations have been observed in pleural and peritoneal …
cavities. Several recurrent alterations have been observed in pleural and peritoneal …
Reliability of assessing morphologic features with prognostic significance in cytology specimens of epithelioid diffuse pleural mesothelioma and implications for …
Abstract Background The World Health Organization incorporates morphologic features with
prognostic significance in the 2021 classification of epithelioid diffuse pleural mesothelioma …
prognostic significance in the 2021 classification of epithelioid diffuse pleural mesothelioma …
Head‐to‐head: Should Ki67 proliferation index be included in the formal classification of pulmonary neuroendocrine neoplasms?
The reporting of lung neuroendocrine neoplasms (NENs) according to the 2021 World
Health Organisation (WHO) is based on mitotic count per 2 mm2, necrosis assessment and …
Health Organisation (WHO) is based on mitotic count per 2 mm2, necrosis assessment and …